J A Beavo
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J A Beavo.
BMC Pharmacology | 2011
Enrico Patrucco; Robert Lukowski; Sergei D. Rybalkin; J A Beavo; Franz Hofmann
Background The heart responds to maladaptive pro-hypertrophic stimuli by stimulating intrinsic signals that contrast and dampen the onset and development of hypertrophy. Cyclic guanosine monophosphate (cGMP) and its downstream effector cGMP kinase I (cGKI) have been suggested to be an important anti-hypertrophic signalling pathway (1). Intracellular levels of cGMP can be raised by the action of nitric oxide (NO) and natriuretic peptides (ANP, BNP), or by inhibiting cGMP-degrading phosphodiesterases (PDE).
Journal of Biological Chemistry | 1982
T J Martins; M C Mumby; J A Beavo
Proceedings of the National Academy of Sciences of the United States of America | 1998
Scott H. Soderling; Sharon J. Bayuga; J A Beavo
Journal of Biological Chemistry | 1988
Peter G. Gillespie; J A Beavo
Proceedings of the National Academy of Sciences of the United States of America | 1995
Chen Yan; Allan Z. Zhao; J. K. Bentley; K. Loughney; K. Ferguson; J A Beavo
Proceedings of the National Academy of Sciences of the United States of America | 2000
Joanna Hetman; Scott H. Soderling; Natalie Glavas; J A Beavo
Reviews of Physiology Biochemistry and Pharmacology | 1999
D. M. Juilfs; Scott H. Soderling; F. Burns; J A Beavo
Proceedings of the National Academy of Sciences of the United States of America | 1989
Peter G. Gillespie; J A Beavo
Journal of Biological Chemistry | 1985
Richard L. Hurwitz; A H Bunt-Milam; M L Chang; J A Beavo
Journal of Biological Chemistry | 1995
Linda M. McAllister-Lucas; Tamara L. Haik; Janet L. Colbran; William K. Sonnenburg; Dalia Seger; Illarion V. Turko; J A Beavo; Sharron H. Francis; Jackie D. Corbin